Global and China Fibromyalgia Treatment Market Insights, Forecast to 2027

Publisher Name :
Date: 15-Oct-2021
No. of pages: 158
Inquire Before Buying

Fibromyalgia Treatment market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Fibromyalgia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Fibromyalgia Treatment market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- Antidepressants

- Anticonvulsants

- Muscle Relaxants

- Narcotic Analgesics

- Non-narcotic Analgesics

Segment by Application

- Hospitals Pharmacies

- Clinic Pharmacy

- Retail Drug Stores

- Online Pharmacies

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Eli Lilly and Company

- Pfizer

- Novartis AG

- Allergan

- Aptinyx

- Prismic Pharmaceuticals

- Innovative Med Concepts

- Intec Pharma Ltd.

- Astellas Pharma

- Savella

- Sun Pharmaceutical Industries

- Mylan NV

- Teva Pharmaceutical Industries

- Daiichi Sankyo

- Forest Pharmaceuticals

- Meiji Seika Pharma

- Tonix Pharmaceuticals

- Theravance Biopharma

Global and China Fibromyalgia Treatment Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Fibromyalgia Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Fibromyalgia Treatment Market Size Growth Rate by Type
1.2.2 Antidepressants
1.2.3 Anticonvulsants
1.2.4 Muscle Relaxants
1.2.5 Narcotic Analgesics
1.2.6 Non-narcotic Analgesics
1.3 Market by Application
1.3.1 Global Fibromyalgia Treatment Market Size Growth Rate by Application
1.3.2 Hospitals Pharmacies
1.3.3 Clinic Pharmacy
1.3.4 Retail Drug Stores
1.3.5 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Fibromyalgia Treatment Market Size, Estimates and Forecasts
2.1.1 Global Fibromyalgia Treatment Revenue 2016-2027
2.1.2 Global Fibromyalgia Treatment Sales 2016-2027
2.2 Global Fibromyalgia Treatment, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Fibromyalgia Treatment Historical Market Size by Region (2016-2021)
2.3.1 Global Fibromyalgia Treatment Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Fibromyalgia Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Fibromyalgia Treatment Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Fibromyalgia Treatment Sales Forecast by Region (2022-2027)
2.4.2 Global Fibromyalgia Treatment Revenue Forecast by Region (2022-2027)
3 Global Fibromyalgia Treatment Competitor Landscape by Players
3.1 Global Top Fibromyalgia Treatment Manufacturers by Sales
3.1.1 Global Fibromyalgia Treatment Sales by Manufacturer (2016-2021)
3.1.2 Global Fibromyalgia Treatment Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Fibromyalgia Treatment Manufacturers by Revenue
3.2.1 Key Fibromyalgia Treatment Manufacturers Covered: Ranking by Revenue
3.2.2 Global Fibromyalgia Treatment Revenue by Manufacturers (2016-2021)
3.2.3 Global Fibromyalgia Treatment Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Fibromyalgia Treatment Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Fibromyalgia Treatment Revenue in 2020
3.2.6 Global Fibromyalgia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Fibromyalgia Treatment Price by Manufacturers
3.4 Global Fibromyalgia Treatment Manufacturing Base Distribution, Product Types
3.4.1 Fibromyalgia Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Fibromyalgia Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Fibromyalgia Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Fibromyalgia Treatment Market Size by Type (2016-2021)
4.1.1 Global Fibromyalgia Treatment Sales by Type (2016-2021)
4.1.2 Global Fibromyalgia Treatment Revenue by Type (2016-2021)
4.1.3 Fibromyalgia Treatment Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Fibromyalgia Treatment Market Size Forecast by Type (2022-2027)
4.2.1 Global Fibromyalgia Treatment Sales Forecast by Type (2022-2027)
4.2.2 Global Fibromyalgia Treatment Revenue Forecast by Type (2022-2027)
4.2.3 Fibromyalgia Treatment Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Fibromyalgia Treatment Market Size by Application (2016-2021)
5.1.1 Global Fibromyalgia Treatment Sales by Application (2016-2021)
5.1.2 Global Fibromyalgia Treatment Revenue by Application (2016-2021)
5.1.3 Fibromyalgia Treatment Price by Application (2016-2021)
5.2 Fibromyalgia Treatment Market Size Forecast by Application (2022-2027)
5.2.1 Global Fibromyalgia Treatment Sales Forecast by Application (2022-2027)
5.2.2 Global Fibromyalgia Treatment Revenue Forecast by Application (2022-2027)
5.2.3 Global Fibromyalgia Treatment Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Fibromyalgia Treatment Market Size YoY Growth 2016-2027
6.1.1 China Fibromyalgia Treatment Sales YoY Growth 2016-2027
6.1.2 China Fibromyalgia Treatment Revenue YoY Growth 2016-2027
6.1.3 China Fibromyalgia Treatment Market Share in Global Market 2016-2027
6.2 China Fibromyalgia Treatment Market Size by Players (International and Local Players)
6.2.1 China Top Fibromyalgia Treatment Players by Sales (2016-2021)
6.2.2 China Top Fibromyalgia Treatment Players by Revenue (2016-2021)
6.3 China Fibromyalgia Treatment Historic Market Review by Type (2016-2021)
6.3.1 China Fibromyalgia Treatment Sales Market Share by Type (2016-2021)
6.3.2 China Fibromyalgia Treatment Revenue Market Share by Type (2016-2021)
6.3.3 China Fibromyalgia Treatment Price by Type (2016-2021)
6.4 China Fibromyalgia Treatment Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Fibromyalgia Treatment Sales Forecast by Type (2022-2027)
6.4.2 China Fibromyalgia Treatment Revenue Forecast by Type (2022-2027)
6.4.3 China Fibromyalgia Treatment Price Forecast by Type (2022-2027)
6.5 China Fibromyalgia Treatment Historic Market Review by Application (2016-2021)
6.5.1 China Fibromyalgia Treatment Sales Market Share by Application (2016-2021)
6.5.2 China Fibromyalgia Treatment Revenue Market Share by Application (2016-2021)
6.5.3 China Fibromyalgia Treatment Price by Application (2016-2021)
6.6 China Fibromyalgia Treatment Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Fibromyalgia Treatment Sales Forecast by Application (2022-2027)
6.6.2 China Fibromyalgia Treatment Revenue Forecast by Application (2022-2027)
6.6.3 China Fibromyalgia Treatment Price Forecast by Application (2022-2027)
7 North America
7.1 North America Fibromyalgia Treatment Market Size YoY Growth 2016-2027
7.2 North America Fibromyalgia Treatment Market Facts & Figures by Country
7.2.1 North America Fibromyalgia Treatment Sales by Country (2016-2021)
7.2.2 North America Fibromyalgia Treatment Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Fibromyalgia Treatment Market Size YoY Growth 2016-2027
8.2 Asia Pacific Fibromyalgia Treatment Market Facts & Figures by Region
8.2.1 Asia Pacific Fibromyalgia Treatment Sales by Region (2016-2021)
8.2.2 Asia Pacific Fibromyalgia Treatment Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Fibromyalgia Treatment Market Size YoY Growth 2016-2027
9.2 Europe Fibromyalgia Treatment Market Facts & Figures by Country
9.2.1 Europe Fibromyalgia Treatment Sales by Country (2016-2021)
9.2.2 Europe Fibromyalgia Treatment Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Fibromyalgia Treatment Market Size YoY Growth 2016-2027
10.2 Latin America Fibromyalgia Treatment Market Facts & Figures by Country
10.2.1 Latin America Fibromyalgia Treatment Sales by Country (2016-2021)
10.2.2 Latin America Fibromyalgia Treatment Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Fibromyalgia Treatment Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Fibromyalgia Treatment Market Facts & Figures by Country
11.2.1 Middle East and Africa Fibromyalgia Treatment Sales by Country (2016-2021)
11.2.2 Middle East and Africa Fibromyalgia Treatment Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Eli Lilly and Company
12.1.1 Eli Lilly and Company Corporation Information
12.1.2 Eli Lilly and Company Description and Business Overview
12.1.3 Eli Lilly and Company Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Eli Lilly and Company Fibromyalgia Treatment Products Offered
12.1.5 Eli Lilly and Company Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Fibromyalgia Treatment Products Offered
12.2.5 Pfizer Recent Development
12.3 Novartis AG
12.3.1 Novartis AG Corporation Information
12.3.2 Novartis AG Description and Business Overview
12.3.3 Novartis AG Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis AG Fibromyalgia Treatment Products Offered
12.3.5 Novartis AG Recent Development
12.4 Allergan
12.4.1 Allergan Corporation Information
12.4.2 Allergan Description and Business Overview
12.4.3 Allergan Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Allergan Fibromyalgia Treatment Products Offered
12.4.5 Allergan Recent Development
12.5 Aptinyx
12.5.1 Aptinyx Corporation Information
12.5.2 Aptinyx Description and Business Overview
12.5.3 Aptinyx Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Aptinyx Fibromyalgia Treatment Products Offered
12.5.5 Aptinyx Recent Development
12.6 Prismic Pharmaceuticals
12.6.1 Prismic Pharmaceuticals Corporation Information
12.6.2 Prismic Pharmaceuticals Description and Business Overview
12.6.3 Prismic Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Prismic Pharmaceuticals Fibromyalgia Treatment Products Offered
12.6.5 Prismic Pharmaceuticals Recent Development
12.7 Innovative Med Concepts
12.7.1 Innovative Med Concepts Corporation Information
12.7.2 Innovative Med Concepts Description and Business Overview
12.7.3 Innovative Med Concepts Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Innovative Med Concepts Fibromyalgia Treatment Products Offered
12.7.5 Innovative Med Concepts Recent Development
12.8 Intec Pharma Ltd.
12.8.1 Intec Pharma Ltd. Corporation Information
12.8.2 Intec Pharma Ltd. Description and Business Overview
12.8.3 Intec Pharma Ltd. Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Intec Pharma Ltd. Fibromyalgia Treatment Products Offered
12.8.5 Intec Pharma Ltd. Recent Development
12.9 Astellas Pharma
12.9.1 Astellas Pharma Corporation Information
12.9.2 Astellas Pharma Description and Business Overview
12.9.3 Astellas Pharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Astellas Pharma Fibromyalgia Treatment Products Offered
12.9.5 Astellas Pharma Recent Development
12.10 Savella
12.10.1 Savella Corporation Information
12.10.2 Savella Description and Business Overview
12.10.3 Savella Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Savella Fibromyalgia Treatment Products Offered
12.10.5 Savella Recent Development
12.11 Eli Lilly and Company
12.11.1 Eli Lilly and Company Corporation Information
12.11.2 Eli Lilly and Company Description and Business Overview
12.11.3 Eli Lilly and Company Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Eli Lilly and Company Fibromyalgia Treatment Products Offered
12.11.5 Eli Lilly and Company Recent Development
12.12 Mylan NV
12.12.1 Mylan NV Corporation Information
12.12.2 Mylan NV Description and Business Overview
12.12.3 Mylan NV Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Mylan NV Products Offered
12.12.5 Mylan NV Recent Development
12.13 Teva Pharmaceutical Industries
12.13.1 Teva Pharmaceutical Industries Corporation Information
12.13.2 Teva Pharmaceutical Industries Description and Business Overview
12.13.3 Teva Pharmaceutical Industries Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Teva Pharmaceutical Industries Products Offered
12.13.5 Teva Pharmaceutical Industries Recent Development
12.14 Daiichi Sankyo
12.14.1 Daiichi Sankyo Corporation Information
12.14.2 Daiichi Sankyo Description and Business Overview
12.14.3 Daiichi Sankyo Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Daiichi Sankyo Products Offered
12.14.5 Daiichi Sankyo Recent Development
12.15 Forest Pharmaceuticals
12.15.1 Forest Pharmaceuticals Corporation Information
12.15.2 Forest Pharmaceuticals Description and Business Overview
12.15.3 Forest Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Forest Pharmaceuticals Products Offered
12.15.5 Forest Pharmaceuticals Recent Development
12.16 Meiji Seika Pharma
12.16.1 Meiji Seika Pharma Corporation Information
12.16.2 Meiji Seika Pharma Description and Business Overview
12.16.3 Meiji Seika Pharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Meiji Seika Pharma Products Offered
12.16.5 Meiji Seika Pharma Recent Development
12.17 Tonix Pharmaceuticals
12.17.1 Tonix Pharmaceuticals Corporation Information
12.17.2 Tonix Pharmaceuticals Description and Business Overview
12.17.3 Tonix Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Tonix Pharmaceuticals Products Offered
12.17.5 Tonix Pharmaceuticals Recent Development
12.18 Theravance Biopharma
12.18.1 Theravance Biopharma Corporation Information
12.18.2 Theravance Biopharma Description and Business Overview
12.18.3 Theravance Biopharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Theravance Biopharma Products Offered
12.18.5 Theravance Biopharma Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Fibromyalgia Treatment Industry Trends
13.2 Fibromyalgia Treatment Market Drivers
13.3 Fibromyalgia Treatment Market Challenges
13.4 Fibromyalgia Treatment Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Fibromyalgia Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Fibromyalgia Treatment Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Antidepressants
Table 3. Major Manufacturers of Anticonvulsants
Table 4. Major Manufacturers of Muscle Relaxants
Table 5. Major Manufacturers of Narcotic Analgesics
Table 6. Major Manufacturers of Non-narcotic Analgesics
Table 7. Global Fibromyalgia Treatment Market Size Growth Rate by Application (2021-2027) & (KG)
Table 8. Global Fibromyalgia Treatment Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Fibromyalgia Treatment Sales by Regions (2016-2021) & (KG)
Table 10. Global Fibromyalgia Treatment Sales Market Share by Regions (2016-2021)
Table 11. Global Fibromyalgia Treatment Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Fibromyalgia Treatment Sales Forecast by Region (2022-2027) & (KG)
Table 13. Global Fibromyalgia Treatment Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Fibromyalgia Treatment Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Fibromyalgia Treatment Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Fibromyalgia Treatment Sales by Manufacturers (2016-2021) (KG)
Table 17. Global Fibromyalgia Treatment Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Fibromyalgia Treatment Manufacturers by Revenue (US$ Million) in 2020
Table 19. Fibromyalgia Treatment Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Fibromyalgia Treatment Revenue Share by Manufacturers (2016-2021)
Table 21. Global Fibromyalgia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Fibromyalgia Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Treatment as of 2020)
Table 23. Key Manufacturers Fibromyalgia Treatment Price (2016-2021) (USD/KG)
Table 24. Fibromyalgia Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Fibromyalgia Treatment Product Type
Table 26. Date of International Manufacturers Enter into Fibromyalgia Treatment Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Fibromyalgia Treatment Sales by Type (2016-2021) (KG)
Table 29. Global Fibromyalgia Treatment Sales Share by Type (2016-2021)
Table 30. Global Fibromyalgia Treatment Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Fibromyalgia Treatment Revenue Share by Type (2016-2021)
Table 32. Fibromyalgia Treatment Average Selling Price (ASP) by Type (2016-2021) & (USD/KG)
Table 33. Global Fibromyalgia Treatment Sales Forecast by Type (2022-2027) & (KG)
Table 34. Global Fibromyalgia Treatment Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Fibromyalgia Treatment Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Fibromyalgia Treatment Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Fibromyalgia Treatment Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/KG)
Table 38. Global Fibromyalgia Treatment Sales by Application (2016-2021) (KG)
Table 39. Global Fibromyalgia Treatment Sales Share by Application (2016-2021)
Table 40. Global Fibromyalgia Treatment Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Fibromyalgia Treatment Revenue Share by Application (2016-2021)
Table 42. Fibromyalgia Treatment Average Selling Price (ASP) by Application (2016-2021) & (USD/KG)
Table 43. Global Fibromyalgia Treatment Sales Forecast by Application (2022-2027) & (KG)
Table 44. Global Fibromyalgia Treatment Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Fibromyalgia Treatment Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Fibromyalgia Treatment Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Fibromyalgia Treatment Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/KG)
Table 48. China Fibromyalgia Treatment Sales (KG) of Key Companies (2016-2021)
Table 49. China Fibromyalgia Treatment Sales Share by Company (2016-2021)
Table 50. China Fibromyalgia Treatment Revenue (US$ Million) by Company (2016-2021)
Table 51. China Fibromyalgia Treatment Revenue Share by Company (2016-2021)
Table 52. China Fibromyalgia Treatment Sales (KG) by Type (2016-2021)
Table 53. China Fibromyalgia Treatment Sales Share by Type (2016-2021)
Table 54. China Fibromyalgia Treatment Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. China Fibromyalgia Treatment Price (USD/KG) by Type (2016-2021)
Table 56. China Fibromyalgia Treatment Sales (KG) by Type (2022-2027)
Table 57. China Fibromyalgia Treatment Sales Share by Type (2022-2027)
Table 58. China Fibromyalgia Treatment Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. China Fibromyalgia Treatment Revenue Share by Type (2022-2027)
Table 60. China Fibromyalgia Treatment Price (USD/KG) by Type (2022-2027)
Table 61. China Fibromyalgia Treatment Sales (KG) by Application (2016-2021)
Table 62. China Fibromyalgia Treatment Sales Share by Application (2016-2021)
Table 63. China Fibromyalgia Treatment Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. China Fibromyalgia Treatment Price (USD/KG) by Application (2016-2021)
Table 65. China Fibromyalgia Treatment Sales (KG) by Application (2022-2027)
Table 66. China Fibromyalgia Treatment Sales Share by Application (2022-2027)
Table 67. China Fibromyalgia Treatment Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. China Fibromyalgia Treatment Revenue Share by Application (2022-2027)
Table 69. China Fibromyalgia Treatment Price (USD/KG) by Application (2022-2027)
Table 70. North America Fibromyalgia Treatment Sales by Country (2016-2021) & (KG)
Table 71. North America Fibromyalgia Treatment Sales Market Share by Country (2016-2021)
Table 72. North America Fibromyalgia Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Fibromyalgia Treatment Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Fibromyalgia Treatment Sales by Region (2016-2021) & (KG)
Table 75. Asia Pacific Fibromyalgia Treatment Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Fibromyalgia Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Fibromyalgia Treatment Revenue Market Share by Region (2016-2021)
Table 78. Europe Fibromyalgia Treatment Sales by Country (2016-2021) & (KG)
Table 79. Europe Fibromyalgia Treatment Sales Market Share by Country (2016-2021)
Table 80. Europe Fibromyalgia Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Fibromyalgia Treatment Revenue Market Share by Country (2016-2021)
Table 82. Latin America Fibromyalgia Treatment Sales by Country (2016-2021) & (KG)
Table 83. Latin America Fibromyalgia Treatment Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Fibromyalgia Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Fibromyalgia Treatment Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Fibromyalgia Treatment Sales by Country (2016-2021) & (KG)
Table 87. Middle East and Africa Fibromyalgia Treatment Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Fibromyalgia Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Fibromyalgia Treatment Revenue Market Share by Country (2016-2021)
Table 90. Eli Lilly and Company Corporation Information
Table 91. Eli Lilly and Company Description and Business Overview
Table 92. Eli Lilly and Company Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 93. Eli Lilly and Company Fibromyalgia Treatment Product
Table 94. Eli Lilly and Company Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 98. Pfizer Product
Table 99. Pfizer Recent Development
Table 100. Novartis AG Corporation Information
Table 101. Novartis AG Description and Business Overview
Table 102. Novartis AG Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 103. Novartis AG Product
Table 104. Novartis AG Recent Development
Table 105. Allergan Corporation Information
Table 106. Allergan Description and Business Overview
Table 107. Allergan Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 108. Allergan Product
Table 109. Allergan Recent Development
Table 110. Aptinyx Corporation Information
Table 111. Aptinyx Description and Business Overview
Table 112. Aptinyx Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 113. Aptinyx Product
Table 114. Aptinyx Recent Development
Table 115. Prismic Pharmaceuticals Corporation Information
Table 116. Prismic Pharmaceuticals Description and Business Overview
Table 117. Prismic Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 118. Prismic Pharmaceuticals Product
Table 119. Prismic Pharmaceuticals Recent Development
Table 120. Innovative Med Concepts Corporation Information
Table 121. Innovative Med Concepts Description and Business Overview
Table 122. Innovative Med Concepts Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 123. Innovative Med Concepts Product
Table 124. Innovative Med Concepts Recent Development
Table 125. Intec Pharma Ltd. Corporation Information
Table 126. Intec Pharma Ltd. Description and Business Overview
Table 127. Intec Pharma Ltd. Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 128. Intec Pharma Ltd. Product
Table 129. Intec Pharma Ltd. Recent Development
Table 130. Astellas Pharma Corporation Information
Table 131. Astellas Pharma Description and Business Overview
Table 132. Astellas Pharma Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 133. Astellas Pharma Product
Table 134. Astellas Pharma Recent Development
Table 135. Savella Corporation Information
Table 136. Savella Description and Business Overview
Table 137. Savella Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 138. Savella Product
Table 139. Savella Recent Development
Table 140. Sun Pharmaceutical Industries Corporation Information
Table 141. Sun Pharmaceutical Industries Description and Business Overview
Table 142. Sun Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 143. Sun Pharmaceutical Industries Product
Table 144. Sun Pharmaceutical Industries Recent Development
Table 145. Mylan NV Corporation Information
Table 146. Mylan NV Description and Business Overview
Table 147. Mylan NV Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 148. Mylan NV Product
Table 149. Mylan NV Recent Development
Table 150. Teva Pharmaceutical Industries Corporation Information
Table 151. Teva Pharmaceutical Industries Description and Business Overview
Table 152. Teva Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 153. Teva Pharmaceutical Industries Product
Table 154. Teva Pharmaceutical Industries Recent Development
Table 155. Daiichi Sankyo Corporation Information
Table 156. Daiichi Sankyo Description and Business Overview
Table 157. Daiichi Sankyo Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 158. Daiichi Sankyo Product
Table 159. Daiichi Sankyo Recent Development
Table 160. Forest Pharmaceuticals Corporation Information
Table 161. Forest Pharmaceuticals Description and Business Overview
Table 162. Forest Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 163. Forest Pharmaceuticals Product
Table 164. Forest Pharmaceuticals Recent Development
Table 165. Meiji Seika Pharma Corporation Information
Table 166. Meiji Seika Pharma Description and Business Overview
Table 167. Meiji Seika Pharma Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 168. Meiji Seika Pharma Product
Table 169. Meiji Seika Pharma Recent Development
Table 170. Tonix Pharmaceuticals Corporation Information
Table 171. Tonix Pharmaceuticals Description and Business Overview
Table 172. Tonix Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 173. Tonix Pharmaceuticals Product
Table 174. Tonix Pharmaceuticals Recent Development
Table 175. Theravance Biopharma Corporation Information
Table 176. Theravance Biopharma Description and Business Overview
Table 177. Theravance Biopharma Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 178. Theravance Biopharma Product
Table 179. Theravance Biopharma Recent Development
Table 180. Fibromyalgia Treatment Market Trends
Table 181. Fibromyalgia Treatment Market Drivers
Table 182. Fibromyalgia Treatment Market Challenges
Table 183. Fibromyalgia Treatment Market Restraints
Table 184. Fibromyalgia Treatment Customers List
Table 185. Fibromyalgia Treatment Distributors List
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Fibromyalgia Treatment Product Picture
Figure 2. Global Fibromyalgia Treatment Sales Market Share by Type in 2020 & 2027
Figure 3. Antidepressants Product Picture
Figure 4. Anticonvulsants Product Picture
Figure 5. Muscle Relaxants Product Picture
Figure 6. Narcotic Analgesics Product Picture
Figure 7. Non-narcotic Analgesics Product Picture
Figure 8. Global Fibromyalgia Treatment Sales Market Share by Application in 2020 & 2027
Figure 9. Hospitals Pharmacies
Figure 10. Clinic Pharmacy
Figure 11. Retail Drug Stores
Figure 12. Online Pharmacies
Figure 13. Fibromyalgia Treatment Report Years Considered
Figure 14. Global Fibromyalgia Treatment Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Fibromyalgia Treatment Market Size 2016-2027 (US$ Million)
Figure 16. Global Fibromyalgia Treatment Sales 2016-2027 (KG)
Figure 17. Global Fibromyalgia Treatment Market Size Market Share by Region: 2021 Versus 2027
Figure 18. Global Fibromyalgia Treatment Sales Market Share by Region (2016-2021)
Figure 19. Global Fibromyalgia Treatment Sales Market Share by Region in 2020
Figure 20. Global Fibromyalgia Treatment Revenue Market Share by Region (2016-2021)
Figure 21. Global Fibromyalgia Treatment Revenue Market Share by Region in 2020
Figure 22. Global Fibromyalgia Treatment Sales Share by Manufacturer in 2020
Figure 23. The Top 10 and 5 Players Market Share by Fibromyalgia Treatment Revenue in 2020
Figure 24. Fibromyalgia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 25. Global Fibromyalgia Treatment Sales Market Share by Type (2016-2021)
Figure 26. Global Fibromyalgia Treatment Sales Market Share by Type in 2020
Figure 27. Global Fibromyalgia Treatment Revenue Market Share by Type (2016-2021)
Figure 28. Global Fibromyalgia Treatment
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs